CV Sciences, Inc.
CVSI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001510964
In the last 90 days, CV Sciences, Inc. insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Market capNo recent closing price
- –
- Insider buysLast 90 days, $169.2K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $13.8M
- −12.2% year over year
- Net income, FY2025
- -$958.0K
- No comparable prior period
- Free cash flow, FY2025
- -$516.0K
- No comparable prior period
- Revenue, Q3 FY2026
- $3.03M
- −7.0% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 6.36K
- Shares sold short
- Change
- −30.3K
- −82.7% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding CVSI, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding CVSI at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by CV Sciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 (view filing)4:19 PM ET | Nov 4-11 | 12 daysLate | Cheever Charlie E III10% Owner | PPurchaseCommon | +5.44M | $0.01 | +$54.4K | +20.4%32.1M after | 5 lots |
| Sep 9, 2026 (view filing)6:43 PM ET | Jul 16-Aug 7 | 55 daysLate | Cheever Charlie E III10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +5.74M | $0.02 | +$114.8K | +27.5%26.6M after | 10 lots |
Top 10 13F holders, Q2 2026
View all: Top 10 13F holders, Q2 2026The largest institutional positions in CV Sciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding CVSI in 13F filings for Q2 2026.
Holders of 5% or more of CVSI
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of CV Sciences, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Cheever Charlie E III | 13G | 13.10%26.6M shares | New | Sep 9, 20261 filing | Sep 9, 2026 | SEC |